BioLineRx (BLRX) Institutional Ownership → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free BLRX Stock Alerts $0.64 0.00 (-0.30%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for BioLineRx (NASDAQ:BLRX)CurrentInstitutional OwnershipPercentage1.56%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$379.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$106.68K Get BLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioLineRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLRX Institutional Buying and Selling by Quarter Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company BioLineRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/12/2024PVG Asset Management Corp61,840$97K0.5%N/A0.085% 2/8/2024 NorthRock Partners LLC17,125$27K0.0%N/A0.024% 12/1/2023 B. Riley Wealth Advisors Inc.21,300$39K0.0%+88.5%0.029% 11/21/2023 Allen Mooney & Barnes Investment Advisors LLC25,000$46K0.0%N/A0.035% 11/13/2023 Rathbones Group PLC39,820$72K0.0%N/A0.065% 11/8/2023 Values First Advisors Inc.48,348$88K0.1%N/A0.079% Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 10/11/2023 Geneos Wealth Management Inc.40,500$74K0.0%+72.3%0.066% 7/31/2023PVG Asset Management Corp61,840$99K0.4%-52.0%0.101% 5/16/2023 Altium Capital Management LP2,279,657$2.02M1.1%-26.5%3.705% 11/14/2022 Armistice Capital LLC2,797,048$2.59M0.0%N/A4.546% 11/14/2022 Altium Capital Management LP4,149,262$3.84M1.4%N/A6.744% 11/8/2022 Apollon Wealth Management LLC48,790$45K0.0%N/A0.079% 11/7/2022Virtu Financial LLC46,168$43K0.0%+195.6%0.075% 10/13/2022PVG Asset Management Corp47,860$44K0.2%N/A0.100% 7/22/2022 Geneos Wealth Management Inc.41,450$53K0.0%+25.8%0.087% 5/13/2022 Parkman Healthcare Partners LLC270,665$463K0.1%-36.9%0.568% 2/9/2022 Geneos Wealth Management Inc.28,950$59K0.0%+63.1%0.061% 2/4/2022 Envestnet Asset Management Inc.122,224$249K0.0%+184.7%0.256% 2/2/2022PVG Asset Management Corp160,360$327K1.2%+109.6%0.336% 1/28/2022 ARK Investment Management LLC1,059,722$2.16M0.0%-1.3%2.223% 11/16/2021 Schonfeld Strategic Advisors LLC12,100$33K0.0%N/A0.025% 11/16/2021 Intellectus Partners LLC28,500$78K0.0%-29.6%0.060% 11/12/2021 Parkman Healthcare Partners LLC411,060$1.13M0.3%-44.0%0.869% 11/10/2021PVG Asset Management Corp76,510$210K0.6%N/A0.162% 10/26/2021 Game Plan Financial Advisors LLC25,000$69K0.0%-13.8%0.053% 9/17/2021Virtu Financial LLC16,578$47K0.0%N/A0.035% 8/13/2021 Renaissance Technologies LLC77,808$219K0.0%-84.6%0.165% 8/11/2021Susquehanna Fundamental Investments LLC19,026$53K0.0%-74.5%0.040% 8/9/2021 Cutter & CO Brokerage Inc.18,667$52K0.0%-34.9%0.039% 5/18/2021 Morgan Stanley398,412$1.11M0.0%-45.6%0.875% 5/18/2021 First Heartland Consultants Inc.10,000$28K0.0%N/A0.023% 5/18/2021 Silverarc Capital Management LLC200,000$558K0.3%N/A0.465% 5/17/2021 Schonfeld Strategic Advisors LLC76,500$213K0.0%+115.5%0.178% 5/17/2021 Intellectus Partners LLC40,500$113K0.0%N/A0.094% 5/17/2021 Goldman Sachs Group Inc.16,621$46K0.0%N/A0.039% 5/13/2021 Renaissance Technologies LLC505,121$1.41M0.0%+89.2%1.174% 4/28/2021 Game Plan Financial Advisors LLC26,000$74K0.0%N/A0.061% 2/12/2021 LPL Financial LLC42,876$108K0.0%+154.1%0.111% 2/10/2021 Rhumbline Advisers14,208$36K0.0%N/A0.037% 1/4/2021 Thomasville National Bank20,325$51K0.0%+62.6%0.089% Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here.11/13/2020 Morgan Stanley768,335$1.26M0.0%+36.0%3.796% 11/5/2020 Cutter & CO Brokerage Inc.29,000$48K0.0%+62.9%0.145% 8/14/2020 Opaleye Management Inc.16,667$29K0.0%N/A0.223% 8/14/2020 BVF Inc. IL1,686,375$2.88M0.2%-2.7%22.551% 8/12/2020 Goldman Sachs Group Inc.37,873$65K0.0%N/A0.506% 7/29/2020Psagot Investment House Ltd.117,000$200K0.0%N/A1.564% 5/15/2020 Jane Street Group LLC52,043$77K0.0%N/A0.696% 5/15/2020 Morgan Stanley343,909$457K0.0%+34.3%4.599% 5/14/2020 Senvest Management LLC523,819$697K0.1%-16.7%7.005% (Data available from 1/1/2016 forward) BLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLRX shares? During the previous two years, 11 institutional investors and hedge funds held shares of BioLineRx. The most heavily invested institutionals were Armistice Capital LLC ($2.59M), Altium Capital Management LP ($2.02M), PVG Asset Management Corp ($97K), Values First Advisors Inc. ($88K), Geneos Wealth Management Inc. ($74K), Rathbones Group PLC ($72K), and Allen Mooney & Barnes Investment Advisors LLC ($46K).Learn more on BLRX's institutional investors. What percentage of BioLineRx stock is owned by institutional investors? 1.56% of BioLineRx stock is owned by institutional investors. Learn more on BLRX's institutional investor holdings. Which institutional investors have been buying BioLineRx stock? Of the 11 institutional investors that purchased BioLineRx stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Altium Capital Management LP ($4.15M), Armistice Capital LLC ($2.80M), PVG Asset Management Corp ($109.70K), Apollon Wealth Management LLC ($48.79K), Values First Advisors Inc. ($48.35K), Rathbones Group PLC ($39.82K), and Virtu Financial LLC ($30.55K). How much institutional buying is happening at BioLineRx? Institutional investors have bought a total of 7,301,144 shares in the last 24 months. This purchase volume represents approximately $6.93M in transactions. Which BioLineRx major shareholders have been selling company stock? The following institutional investors have sold BioLineRx stock in the last 24 months: Altium Capital Management LP ($823.98K), and PVG Asset Management Corp ($66.89K). How much institutional selling is happening at BioLineRx? Institutional investors have sold a total of 890,863 shares in the last 24 months. This volume of shares sold represents approximately $837.14K in transactions. Related Companies: RVPH Institutional Ownership BOLT Institutional Ownership RMTI Institutional Ownership CLNN Institutional Ownership RPHM Institutional Ownership EQ Institutional Ownership IMRX Institutional Ownership CKPT Institutional Ownership AADI Institutional Ownership KZR Institutional Ownership This page (NASDAQ:BLRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.